[10] By contrast, nafcillin, a semisynthetic penicillin extensively used as the drug of choice for treatment of a number of meticillin-sensitive S. aureus (MSSA) infections such as endocarditis ...

Among the common diseases of the heart, none has been so resistant to treatment and so invariably fatal as subacute bacterial endocarditis. Although isolated cures occurred before the introduction ...

CHF: Congestive heart failure; CI: Contraindication; DM: Diabetes mellitus; ICU: Intensive care unit; IE: Infective endocarditis ... of days or weeks antibiotic treatment under careful clinical ...

Lung cancer survival without treatment is shorter than survival with treatment. People with untreated non-small cell lung cancer—the most common type—typically live between five and 12 months after ...

There are a wide variety of treatment options to help you lose weight. Treatments include nutrition, exercise, medications, procedures, and other therapies that help people lose excess weight. A ...

Treatment for sleep apnea aims to improve your breathing during sleep and reduce the risk of underlying health concerns. Common options include CPAP machines, oral devices, and lifestyle measures ...

Whatever form it takes, successful treatment reverses the changes in brain circuitry that make substance use hard to control. Yet many factors other than biology must be addressed for treatment to ...

A "groundbreaking" £1.65 million treatment has been approved for use on the NHS, offering patients with severe sickle cell disease some hope of a cure. It is believed around 1,700 people could be ...

For both reasons, each person’s treatment plan will be different. Read on to learn about the types of MS treatments available. Disease-modifying therapies (DMTs) can reduce the frequency and ...

Like every other disorder, anxiety needs treatment when, through frequency or intensity, or both, worry interferes with functioning. Anxiety encourages the maladaptive response of avoidance of ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...